CapsoVision, Inc Deferred Revenue Recognized
CapsoVision, Inc (CV) reported Deferred Revenue Recognized of $177.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2026-08-13
- CapsoVision, Inc contract with customer, liability, revenue recognized for the quarter ending 2026-03-31 was $177.00K.
- CapsoVision, Inc contract with customer, liability, revenue recognized for fiscal 2025 was $132.00K.
| Period end | Contract with Customer, Liability, Revenue Recognized 3 month | Contract with Customer, Liability, Revenue Recognized 6 month | Contract with Customer, Liability, Revenue Recognized 12 month |
|---|---|---|---|
| 2026-06-30 | $177.00K 10-Q · filed 2026-08-13 | ||
| 2026-03-31 | $177.00K 10-Q · filed 2026-05-14 | ||
| 2025-12-31 | $132.00K 10-K · filed 2026-03-26 | ||
| 2025-06-30 | $132.00K 10-Q · filed 2026-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B |